Tambong, Marilou .
HRN: 27-85-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2025
CLINDAMYCIN 300MG (CAP)
10/02/2025
10/09/2025
PO
300mg
TID
DM Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes